Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65, a Differentiated CLDN6-Targeting ADC, Powered by AxcynDOT™ Technology AT03-65 is the first program utilizing AxcynDOT™, a proprietary payload with a… CISION PRNewswireJanuary 15, 2025
Small white apricot seeds from Xinjiang have embarked on a space mission to usher in a new era of variety development TURFAN, China, Jan. 15, 2025 /PRNewswire/ — On January 13, 2024, small… CISION PRNewswireJanuary 15, 2025
Press ReleaseSDS Australia Partners with Leading European Sauna Brand Auroom SYDNEY, Jan. 15, 2025 /PRNewswire/ — SDS Australia is proud to announce an exclusive… CISION PRNewswireJanuary 15, 2025
Press ReleaseCountdown to FITUR 2025: The Key Global Event for the Tourism Industry Brazil Takes Center Stage as Partner Country in a Growing Edition with… CISION PRNewswireJanuary 15, 2025
Press ReleaseLeadership change fuels Busways' strategic ambitions SYDNEY, Jan. 15, 2025 /PRNewswire/ — Busways, the largest Australian-owned bus operator, has… CISION PRNewswireJanuary 15, 2025
Nature's Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq ONTARIO, Calif., Jan. 15, 2025 /PRNewswire/ — Nature’s Miracle Holding Inc. (NASDAQ:… CISION PRNewswireJanuary 15, 2025
Solidion Technology's Chief Science Officer Delivers Keynote at Prestigious Advanced Materials Summit in Abu Dhabi Dr. Bor Jang Showcases Graphene’s Transformative Potential for Next-Generation Energy Storage Solutions DAYTON,… CISION PRNewswireJanuary 15, 2025
Press ReleaseVerkada Expands Leadership Team to Drive JAPAC Channel Growth Boudewijn Pesch Joins Verkada as Vice President of JAPAC Channel Sales SAN… CISION PRNewswireJanuary 15, 2025
